Investigating urachal carcinoma for more than 15 years
- PMID: 25295114
- PMCID: PMC4186584
- DOI: 10.3892/ol.2014.2502
Investigating urachal carcinoma for more than 15 years
Abstract
Urachal carcinomas are rare bladder malignances, which usually present at an advanced stage with a high risk of distant metastases and a poor prognosis. To improve understanding of this uncommon carcinoma, a retrospective review was conducted for the cases observed at Peking University Shenzhen Hospital and Peking University First Hospital. The clinical outcomes were analyzed for 17 patients with a diagnosis of urachal cancer, who were admitted to Peking University Shenzhen Hospital (Shenzhen, China) and Peking University First Hospital (Beijing, China) between 1998 and 2013. The TNM staging system was used to predict outcomes. Among the 17 study patients, there were 10 males and seven females, with a median age at diagnosis of 50 years. A total of four (23%) patients presented with lymph node or distant metastasis. The median overall survival time for all stages was 57.6 months, with five patients (38.4%) alive for more than five years following treatment. The application of the TNM staging system demonstrated a median survival time of 6.2 years for stage I/II patients, compared with a median survival of 1.8 years (log-rank, P<0.001) for patients with advanced disease (stages III and IV). In addition, no significant correlation was observed between tumor size and age, and survival. In conclusion, urachal carcinomas are usually locally advanced at presentation. Surgical excision remains the predominant choice of treatment and lymph node dissection is not required unless lymph node involvement is confirmed by preoperative examination. The current results indicated that the most significant predictor of prognosis was the tumor grade.
Keywords: survival; tumor grade; urachal carcinoma.
Figures




Similar articles
-
Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.Cancer. 2007 Dec 1;110(11):2434-40. doi: 10.1002/cncr.23070. Cancer. 2007. PMID: 17932892
-
[Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1136-1141. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30370512 Chinese.
-
Gastric cancers in Singapore: poor prognosis arising from late presentation.Aust N Z J Surg. 1996 Dec;66(12):813-5. doi: 10.1111/j.1445-2197.1996.tb00755.x. Aust N Z J Surg. 1996. PMID: 8996060
-
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Am J Surg Pathol. 2012. PMID: 22301493 Review.
-
Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.Urol Int. 2012;88(2):209-14. doi: 10.1159/000334414. Epub 2011 Dec 3. Urol Int. 2012. PMID: 22143067 Review.
Cited by
-
Urachal Carcinoma: Are Lymphadenectomy and Umbilectomy Necessary?Med Sci Monit. 2020 Sep 22;26:e927913. doi: 10.12659/MSM.927913. Med Sci Monit. 2020. PMID: 32958737 Free PMC article.
-
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice.Eur Urol Open Sci. 2022 Mar 14;39:1-6. doi: 10.1016/j.euros.2022.02.009. eCollection 2022 May. Eur Urol Open Sci. 2022. PMID: 35309098 Free PMC article. Review.
-
Primary Urachal Squamous Cell Carcinoma: A Case Report.Cureus. 2024 Oct 1;16(10):e70604. doi: 10.7759/cureus.70604. eCollection 2024 Oct. Cureus. 2024. PMID: 39483577 Free PMC article.
-
Urachal carcinoma initially presenting only as a liver metastasis, a diagnostic and therapeutic challenge: first case in literature.Ann Med Surg (Lond). 2024 Aug 26;86(10):6236-6240. doi: 10.1097/MS9.0000000000002499. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359809 Free PMC article.
-
Surgical treatment of urachal remnants in an adult population-a single-centre experience.Ir J Med Sci. 2023 Dec;192(6):3023-3027. doi: 10.1007/s11845-023-03339-0. Epub 2023 Mar 20. Ir J Med Sci. 2023. PMID: 36935447 Free PMC article. Review.
References
-
- Ashley RA, Inman BA, Routh JC, et al. Urachal anomalies: a longitudinal study of urachal remnants in children and adults. J Urol. 2007;178(4 Pt 2):1615–1618. - PubMed
-
- Snyder CL. Current management of umbilical abnormalities and related anomalies. Semin Pediatr Surg. 2007;16:41–49. - PubMed
-
- Paras FA, Jr, Maclennan GT. Urachal adenocarcinoma. J Urol. 2008;180:720. - PubMed
-
- Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003;169:1295–1298. - PubMed
-
- Thieblemont C, Fendler JP, Trillet-Lenoir V, et al. Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy. Bull Cancer. 1996;83:139–146. (In French) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources